Evidence map›Paper›PMID 26402069›Full record

ArticlePLoS neglected tropical diseases2015

Assessment and Treatment of Pain during Treatment of Buruli Ulcer.

Janine de Zeeuw, Marike Alferink, Yves T Barogui, Ghislain Sopoh, Richard O Phillips, Tjip S van der Werf, Susanne Loth, Bouwe Molenbuur, Mirjam Plantinga, Adelita V Ranchor and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Pharmacologic management ofExpert review of clinical pharmacology · 2020
    Review
  3. Observational
  4. Article
  5. Experiences of Pain and Expectations for Its Treatment Among Former Buruli Ulcer Patients.The American journal of tropical medicine and hygiene · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Janine de ZeeuwUniversity of Groningen, University Medical Center Groningen, Department of Internal Medicine/Infectious Diseases, Groningen, The Netherlands.
Marike AlferinkUniversity of Groningen, University Medical Center Groningen, Department of Health Psychology, Groningen, The Netherlands.
Yves T BaroguiProgramme National de Lutte contre la Lèpre et l´Ulcère de Buruli, Ministère de la Santé, Cotonou, République du Bénin.
Ghislain SopohProgramme National de Lutte contre la Lèpre et l´Ulcère de Buruli, Ministère de la Santé, Cotonou, République du Bénin.
Richard O PhillipsKwame Nkrumah University of Science and Technology, School of Medical Sciences, Department of Medicine, Kumasi, Ghana.
Tjip S van der WerfUniversity of Groningen, University Medical Center Groningen, Department of Internal Medicine/Infectious Diseases, Groningen, The Netherlands.
Susanne LothUniversity of Groningen, University Medical Center Groningen, Department of Internal Medicine/Infectious Diseases, Groningen, The Netherlands.
Bouwe MolenbuurUniversity of Groningen, University Medical Center Groningen, Department of Anesthesiology, Groningen, The Netherlands.
Mirjam PlantingaUniversity of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
Adelita V RanchorUniversity of Groningen, University Medical Center Groningen, Department of Health Psychology, Groningen, The Netherlands.
Ymkje StienstraUniversity of Groningen, University Medical Center Groningen, Department of Internal Medicine/Infectious Diseases, Groningen, The Netherlands.
University Medical Center Groningen · NLMinistère de la Santé · TNUniversity of Groningen · NLKwame Nkrumah University of Science and Technology · GH

Funding

Medical Research Council MR/J01477X/1
6 · The paper itself

Abstract

backgroundBuruli ulcer (BU) is described as a relatively painless condition; however clinical observations reveal that patients do experience pain during their treatment. Knowledge on current pain assessment and treatment in BU is necessary to develop and implement a future guideline on pain management in BU. METHODOLOGY: A mixed methods approach was used, consisting of information retrieved from medical records on prescribed pain medication from Ghana and Benin, and semi-structured interviews with health care personnel (HCP) from Ghana on pain perceptions, assessment and treatment. Medical records (n = 149) of patients treated between 2008 and 2012 were collected between November 2012 and August 2013. Interviews (n = 11) were audio-taped, transcribed verbatim and qualitatively analyzed. PRINCIPAL

findingsIn 113 (84%) of the 135 included records, pain medication, mostly simple analgesics, was prescribed. In 48% of the prescriptions, an indication was not documented. HCP reported that advanced BU could be painful, especially after wound care and after a skin graft. They reported not be trained in the assessment of mild pain. Pain recognition was perceived as difficult, as patients were said to suppress or to exaggerate pain, and to have different expectations regarding acceptable pain levels. HCP reported a fear of side effects of pain medication, shortage and irregularities in the supply of pain medication, and time constraints among medical doctors for pain management.

conclusionsProfessionals perceived BU disease as potentially painful, and predominantly focused on severe pain. Our study suggests that pain in BU deserves attention and should be integrated in current treatment.

Indexed as

AdolescentAdultAnalgesicsBeninBuruli UlcerChildDrug UtilizationFemaleGhanaHumansInterviews as TopicMaleMedical RecordsPainYoung AdultAnalgesics

Identifiers

PMID26402069
PMCPMC4581868
OpenAlexW1865532779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.